Saturday, May 26

The California Institute for Regenerative Medicine is funding clinical trials at UCLA that involves the injection of drugs optimized for each patient to treat tumors.  (MacKenzie Coffman/Daily Bruin)

Clinical trials for new lung cancer treatment at UCLA receives $12M grant

UCLA researchers received a $12 million grant to start clinical trials of a new treatment for advanced-stage lung cancer. The California Institute for Regenerative Medicine, an organization that funds stem cell research to accelerate advances in medicine, awarded the grant to the labs of Steven Dubinett, the director of the UCLA Jonsson Comprehensive Cancer Center’s lung cancer research program, and Edward Garon, an associate professor of hematology and oncology at the David Geffen School of Medicine, on Thursday. Read more...

The California Institute for Regenerative Medicine is funding clinical trials at UCLA that involves the injection of drugs optimized for each patient to treat tumors.  (MacKenzie Coffman/Daily Bruin)

(Ludi Zhu/Daily Bruin)
(Ludi Zhu/Daily Bruin)

vaccine-01.png
vaccine-01.png

The Organization for Cultural Diversity in Science (OCDS), which aims to empower underrepresented groups in the sciences, held a Spring Science and Engineering Showcase to encourage community college students to pursue STEM in higher education. (Amy Dixon/Assistant photo editor)
The Organization for Cultural Diversity in Science (OCDS), which aims to empower underrepresented groups in the sciences, held a Spring Science and Engineering Showcase to encourage community college students to pursue STEM in higher education. (Amy Dixon/Assistant photo editor)

The 3 Wishes Project grants wishes to terminally ill patients in UCLA’s medical ICU as part of a multicenter research trial started in Canada in December 2017. (Courtesy of Thanh Neville)
The 3 Wishes Project grants wishes to terminally ill patients in UCLA’s medical ICU as part of a multicenter research trial started in Canada in December 2017. (Courtesy of Thanh Neville)

UCLA alumnus Freeman Shen said he originally wanted to pursue a degree in architecture but was unable to do so because he was color blind. Instead, he decided to design vehicles, which he said is more challenging than designing buildings because cars are moving objects. (Liz Ketcham/Daily Bruin)
UCLA alumnus Freeman Shen said he originally wanted to pursue a degree in architecture but was unable to do so because he was color blind. Instead, he decided to design vehicles, which he said is more challenging than designing buildings because cars are moving objects. (Liz Ketcham/Daily Bruin)

Researchers found that patients treated by older surgeons had lower death rates within 30 days of their procedures than those treated by younger surgeons. (Niveda Tennety/Daily Bruin)
Researchers found that patients treated by older surgeons had lower death rates within 30 days of their procedures than those treated by younger surgeons. (Niveda Tennety/Daily Bruin)


1 2 3 187